Table 4.
Unstd. Coeff. | SE | t | |
---|---|---|---|
Positive Affectt | |||
Ruminationt-1, clinical group (γ10) | −0.002 | 0.001 | −2.01* |
CTL group contrast (γ11) | −0.001 | 0.001 | −0.76 |
Worryt-1, clinical group (γ20) | −0.001 | 0.001 | −0.94 |
CTL group contrast (γ21) | 0.002 | 0.002 | 1.26 |
Positive affectt-1, clinical group (γ30) | 0.296 | 0.032 | 9.22*** |
CTL group contrast (γ31) | 0.017 | 0.080 | 0.21 |
Negative Affectt | |||
Ruminationt-1, clinical group (γ10) | 0.002 | 0.001 | 2.08* |
CTL group contrast (γ11) | −0.000 | 0.001 | −0.00 |
Worryt-1, clinical group (γ20) | 0.001 | 0.001 | 1.01 |
CTL group contrast (γ21) | −0.002 | 0.001 | −2.03* |
Negative affectt-1, clinical group (γ30) | 0.188 | 0.042 | 4.53*** |
CTL group contrast (γ31) | −0.055 | 0.062 | −0.88 |
Note. CTL = no past or current psychiatric disorder (n = 19). Clinical group represents the estimate in the MDD, GAD, and MDD-GAD groups combined (n = 51). CTL group contrast represents the difference between the estimates in the clinical group and the CTL group. t-1 denotes the previous prompt. All covariates are presented. Effects are denoted only when they are statistically significant.
p < .05;
p < .001.